Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms.
Reka VarnaiTihamer MolnarLaszlo ZavoriMargit Tőkés-FüzesiZsolt IllesAndrea KanizsaiPeter CsecseiPublished in: Vaccines (2022)
The immune response against the SARS-CoV-2 nucleocapsid may play a more important role than the spike in the course of long-term COVID syndrome.